MedTrace Logo

A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe

NCT04937777 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4481

Last updated 2022-09-27

No results posted yet for this study

Summary

This is a retrospective, observational, multicenter study to collect Real-World Evidence (RWE) data on systemic AL-AMY patients in Europe. Data from paper/electronic medical records and/or electronic databases from key reference centers in Europe will be used. Data will either be entered by the site staff in the electronic Case Report Form (eCRF) or, where feasible, transferred directly, always in accordance to local regulations.

Conditions

  • AL Amyloidosis

Sponsors & Collaborators

  • European Myeloma Network B.V.

    lead NETWORK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-23
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • Austria
  • Czechia
  • France
  • Germany
  • Greece
  • Italy
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04937777 on ClinicalTrials.gov